KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
KAMADA LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 21.7
- Dividend yield
- –
KAMADA LTD revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable segments [Member] | $54.92M | $45.24M | $44.68M | $47.01M | $44.75M | $44.02M | $39.01M | $41.74M | $42.47M | $37.74M | $36.43M | $37.93M | 100.0% | +22.7% |
| Distribution [Member] | – | – | – | – | – | – | – | – | – | – | – | $6.50K | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proprietary Products [Member] | $47.70M | $36.23M | $38.23M | $39.52M | $38.44M | $40.02M | $31.42M | $37.13M | $39.15M | $33.76M | – | – | 86.9% | +24.1% |
| Proprietary Products [Member] | $47.70M | $36.23M | $38.23M | $39.52M | $38.44M | $40.02M | $31.42M | $37.13M | – | – | – | – | 86.9% | +24.1% |
| Distribution | $7.22M | $9.01M | $6.45M | $7.49M | $6.32M | $4.00M | $7.59M | $4.61M | $3.33M | $3.98M | – | – | 13.1% | +14.3% |
| Distribution [Member] | $7.22M | $9.01M | $6.45M | $7.49M | $6.32M | $4.00M | $7.59M | $4.61M | – | – | – | – | 13.1% | +14.3% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | – | – | – | – | $29.32M | – | – | – | – | – |
| Israel | – | – | – | – | – | – | – | – | $5.05M | – | – | – | – | – |
| Asia [Member] | – | – | – | – | – | – | – | – | $66.00K | – | – | – | – | – |
| Latin America [Member] | – | – | – | – | – | – | – | – | $4.12M | – | – | – | – | – |
| Canada | – | – | – | – | – | – | – | – | $2.48M | – | – | – | – | – |
| Europe [Member] | – | – | – | – | – | – | – | – | $1.43M | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Kamada's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.